ACP-0052

N/A

Report date: 2022/12/31 17:30:10
NME

Base Information

Drug NameACP-0052
Drug Alias NamePhotodynamic cancer therapy (SL052)Nanoparticle formulation of SL052 (for IV administration)SL-052-PDTACP-0052SL-052 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhotosensitizers
TargetsUpdating
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesQuest Pharmatech Inc
China Registration ClassN/A

Develop Information

Active CompaniesQuest Pharmatech Inc
Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A